Basics Cogent Biosciences, Inc. IPO Date: March 26, 2018 Sector: Healthcare Industry: Biotech Market Cap: $584.08M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.25% Avg Daily Range (30 D): $0.23 | 4.77% Avg Daily Range (90 D): $0.24 | 3.66% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): 1.13M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 104 Avg Trade Size (Sh.) (90 D): 102 Institutional Trades Total Inst.Trades: 1,462 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $1.04M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $.76M Avg Closing Trade (90 D): $1.07M Avg Closing Volume: 182.42K         News Apr 15, 2025 @ 5:00 PM Gastrointestinal Stromal Tumor Market to Grow Rapi... Source: Delveinsight Jun 28, 2024 @ 1:18 PM Cogent (COGT) Up on SUMMIT Study Update Post Posit... Source: Zacks Equity Research Jun 14, 2024 @ 11:30 AM Cogent Biosciences Announces Additional Clinical D... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:05 PM Cogent Biosciences Appoints Cole Pinnow as Chief C... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:01 PM Cogent Biosciences Announces Positive Updated Lead... Source: Cogent Biosciences, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.84 $-.52 $-.09 Diluted EPS $-1.84 $-.52 $-.09 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -269.5M $ -71.99M $ -67.93M Operating Income / Loss $ -288.47M $ -74.93M $ -73.73M Cost of Revenue $ $ $ Net Cash Flow $ -89.8M $ 27.84M $ 1.12M PE Ratio     Splits Nov 09, 2020:   4:1